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FIGURE 4 | Continued
There was an inadvertent error in Figure 4,
panel (F), pertaining to the effect of
the iNT-Cx50a peptide on the sper-
mine block of rat Cx40 gap junctions.
The data that originally appeared in
this figure was the same data plot-
ted in Figure 4, panel (B) for the iNT-
Cx40b peptide. The data in Figure 4B
is correct and the correct data for the
iNT-Cx50a (n = 4) is now illustrated in
this revised version of Figure 4 for the
original manuscript. The corresponding
author regrets the error that occurred
while configuring the figures for this
manuscript and accepts sole responsibility
for this mistake. The iNT-Cx50a peptide
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FIGURE 4 | (A) The sensitivity of four connexin-specific gap
junctions was tested using the 2mM spermine block assay.
Human Cx40 (hCx40, ) displayed similar Vj-dependent
sensitivity to spermine as rCx40 despite the N9 substitution.
Cx37 (), Cx46 (◦), and Cx50 (•) gap junctions were all
≥60% inhibited by spermine. The maximum inhibition of Cx37
gj occurred at +20mV, half the Vj required for maximal block
of any other known connexin-specific gap junction. (B) The
ability of iNT-Cx40 peptides to interfere with spermine block
was tested by adding 500µM spermine and iNT-Cx40a or
iNT–Cx40b peptides to one patch pipette. The carboxyl-terminal
hydroxylated (−OH, z = −4) form of the Cx40 peptide (Cx40b)
effectively abolished the Vj-dependent spermine block, while
the amidated form (Cx40a, −NH2, z = −3) was only partially
effective (ANOVA, f -value < 0.05). (C) I2 current traces
from an rCx40 cell pair with 500µM spermine added to cell
1. Ij decreased during the positive 30, 40, and 50mV Vj
pulses and returned to prepulse levels during subsequent
negative Vj pulses, This illustrates the time- and Vj-dependent
spermine block and unblock of rCx40 gap junctions. (D) I2
current traces from an rCx40 cell pair experiment with
500µM spermine and the iNT-Cx40b peptide added to cell 1.
Accounting for the occurrence of Vj-dependent gating at
Vj ≥ ±40mV, instantaneous and steady state I2 increased in a
stepwise (ohmic) fashion with increasing Vj amplitude,
indicative of a lack of spermine block. (E) A negatively
charged (z = −4) iNT-Cx50b peptide failed to significantly
prevent the 500µM spermine block of rCx40 gap junctions,
suggesting that the bimolecular interactions between the
rCx40 NT domain, spermine, and iNT peptides are not purely
based on electrostatic forces. (F) An iNT-Cx50a peptide [based
on amino acids 9–13 and possessing a carboxyl-terminal
valence (z) of −3] significantly reduced the 500µM spermine
block of rCx40 gap junctions, suggesting a structural
requirement for the interactions of iNT-Cx peptides with NT
domains or spermine molecules.
was 95% effective in preventing the inhi-
bition of Cx40 gap junctions by 500
microM spermine and inclusion of the
correct data for the iNT-Cx50a peptide
does not alter the results or conclusion
of the original manuscript, just the accu-
racy of reporting the experimental data.
The legend for Figure 4 is not affected
in any way and is reproduced here in its
entirety.
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